Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
about
Viral hepatitis and hepatocellular carcinomaPeginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis CPeginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis CPegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis CDirect interaction between nucleolin and hepatitis C virus NS5BPhosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replicationVitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patientsPrimary care physicians' approach to diagnosis and treatment of hepatitis B and hepatitis C patientsRisk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study.The modeled structure of the RNA dependent RNA polymerase of GBV-C virus suggests a role for motif E in Flaviviridae RNA polymerases.Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-AnalysisHepatitis C cirrhosis: New perspectives for diagnosis and treatmentCurrent molecular methods for the detection of hepatitis C virus in high risk group population: A systematic reviewConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaDirect acting antivirals for the treatment of chronic viral hepatitisBurden of pediatric hepatitis CHyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyproteinIntrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinImpact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.Structurally conserved amino Acid w501 is required for RNA helicase activity but is not essential for DNA helicase activity of hepatitis C virus NS3 protein.Analysis of hepatitis C virus RNA dimerization and core-RNA interactionsGene Expression Profiling of the Cellular Transcriptional Network Regulated by Alpha/Beta Interferon and Its Partial Attenuation by the Hepatitis C Virus Nonstructural 5A ProteinHigh-Affinity Aptamers to Subtype 3a Hepatitis C Virus Polymerase Display Genotypic SpecificityRelationships between Hepatitis C Virus Replication and CXCL-8 Production In VitroIdentification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingNovel Robust Hepatitis C Virus Mouse Efficacy ModelFrequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West AfricaRegulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus InfectionViral Determinants of Resistance to Treatment in Patients with Hepatitis CSevere fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexLiver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionSimultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesionsUpregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune DysfunctionHepatitis B virus and hepatitis C virus in pregnant Sudanese womenStrategic Approach To Produce Low-Cost, Efficient, and Stable Competitive Internal Controls for Detection of RNA Viruses by Use of Reverse Transcription-PCRDesign, expression, and purification of a Flaviviridae polymerase using a high-throughput approach to facilitate crystal structure determinationSeroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar
P2860
Q21245597-5C9E3E81-032A-465D-A1BC-7E1232777CE9Q24200189-C5D978EA-FB62-4BE7-AD24-13EB49179169Q24200197-5EAFF2A3-F52A-4BFE-95C0-2043D9C056C8Q24241360-AD245CA0-D1CF-413C-B9EE-0E9FBF440CE5Q24317623-A51C08DD-559F-4211-9B2D-56F002CE60FAQ24561987-1058A4BF-D8A8-4AC6-8707-249448B42071Q24624237-50A3DF90-6607-4548-A9D1-021A6A702E59Q24799030-BBB7FE28-C184-4FE6-9A72-A77146C8DB3FQ24800271-339F29B6-168D-4B49-8620-E09C3AB9073DQ24810541-A7A1C267-7E0F-4B24-934E-DBDDF785474CQ26747679-85A8D60E-9C9E-4147-850D-58756A1D1307Q26799924-3AA73C74-B0BD-4B87-8A81-7F71F8BF5872Q26851978-5FC1BBCE-00FC-4DD5-A680-8357E1E17FEFQ27010612-4DAEB528-4A0A-45CA-9056-2EFA13A864C5Q27022216-4A7543E2-B246-4529-94F0-D83D935933D3Q27025476-C2A4EDE8-50E4-4D9F-9829-F31CE7913139Q27469751-FE2BAED5-B60D-4F21-8FF8-60DEBAD3692FQ27469851-BEA33734-3838-4D02-B1E3-DC54DD88CFBDQ27470798-7E82768C-A2B3-4830-A8E1-23C2A24F7D19Q27471038-89C55B27-0E34-41C1-BF59-D811D6C21B2AQ27472668-34333952-EFAB-419D-A54E-ECC7A95C43B1Q27472900-8346896E-ED70-4558-BDAE-86351EDD75BEQ27473068-99A3BE13-9499-4EA0-A848-96316B3C6D32Q27473200-451A586A-7868-4B01-88C4-0D4D7B4F9E99Q27473508-A1266FAA-D089-440A-B98B-FD201222C3FEQ27477457-D5C85137-4A2C-4BAA-BF00-DA3E65D50146Q27477464-9BC56A7B-F3CF-455A-9525-F4219425754AQ27477468-A5E46667-B86C-4155-990C-306180C8F662Q27477521-843F812F-2D46-4ED0-A749-D1A68DCED75AQ27477557-5E4FCD82-CC4F-4CEB-A8EE-0855A1170075Q27478028-884E64AB-808B-4B4F-9B43-0BEEA6D64978Q27478062-714ED8C8-83F3-4303-86C7-1FFD31AE3947Q27478140-9F478A10-E5B8-4DC2-95D9-47A72ECE35EFQ27478366-C3DD1AE2-33CF-4420-A2D1-BB83B122978CQ27480734-A145D258-7C85-49EB-83AA-9DC51B79010AQ27481027-D0FA279D-BAE1-4251-B851-C7D82752E7E4Q27482475-88597073-C19F-49EC-ADEA-45558591D1B3Q27484878-51EFBE4D-907A-4937-A7EE-A7B0E9A7622BQ27485674-F49CB383-874F-4083-B8EB-84C2298DE4FAQ27485718-07B195C0-85AE-4D72-B0F6-B8EDDA283EB0
P2860
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
description
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Jahr 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 1999)
@en
wetenschappelijk artikel (gepubliceerd in 1999-01)
@nl
наукова стаття, опублікована в січні 1999
@uk
مقالة علمية (نشرت عام 1999)
@ar
name
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@ast
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@en
type
label
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@ast
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@en
prefLabel
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@ast
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@en
P921
P3181
P1476
Global surveillance and contro ...... ention Board, Antwerp, Belgium
@en
P3181
P356
10.1046/J.1365-2893.1999.6120139.X
P407
P577
1999-01-01T00:00:00Z